The mechanisms underlying the dual effects of STIM1 on prostate cancer are complex, and a recent study showed that some genes or signals, such as TGF-β1, promote cell death and the EMT concurrently in the same types of cell line59. This evidence concerns the gene TGFB1 and prostate cancer.